We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now


It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

TARS Tarsus Pharmaceuticals Inc

-0.30 (-1.81%)
Dec 02 2023 - Closed
Delayed by 15 minutes


Draw Mode:

Volume 756,553
Bid Price 12.59
Ask Price 20.00
News (2)
Day High 16.71


52 Week Range


Day Low 15.75
Company Name Stock Ticker Symbol Market Type
Tarsus Pharmaceuticals Inc TARS NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.30 -1.81% 16.23 00:00:02
Open Price Low Price High Price Close Price Prev Close
16.71 15.75 16.71 15.86 16.53
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
7,287 756,553 $ 16.06 $ 12,147,081 - 11.33 - 25.25
Last Trade Time Type Quantity Stock Price Currency
18:53:10 2 $ 16.20 USD

Tarsus Pharmaceuticals Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
524.71M 33.10M - 25.82M -62.09M -1.88 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Tarsus Pharmaceuticals News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No TARS Message Board. Create One! See More Posts on TARS Message Board See More Message Board Posts

Historical TARS Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week17.5017.9815.7516.68535,385-1.27-7.26%
1 Month14.9319.3414.8717.01715,1011.308.71%
3 Months15.4919.3412.5716.09534,1570.744.78%
6 Months16.8425.2512.5717.24467,966-0.61-3.62%
1 Year16.8125.2511.3316.74293,057-0.58-3.45%
3 Years24.3563.6910.800118.58151,007-8.12-33.35%
5 Years18.3063.6910.800118.65148,036-2.07-11.31%

Tarsus Pharmaceuticals Description

Tarsus Pharmaceuticals Inc is a late clinical-stage biopharmaceutical company. It is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's lead candidate TP-03, is a novel drug that targets the Demodex mite nervous system to kill the mites.

Your Recent History

Delayed Upgrade Clock

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: 1-888-992-3836 |